Radiofrequency ablation combined with immunotherapy to treat hepatocellular carcinoma: a comprehensive review
Abstract Background and aim Hepatocellular carcinoma (HCC) is a highly immunogenic tumor and the third leading cause of cancer-related deaths worldwide with an increasing incidence. Therefore, the combination of immunotherapy with other approaches, such as anti-angiogenic agents and local area thera...
Saved in:
Main Authors: | Gui-Lin Xie, Zhi-Han Zhong, Tai-Wei Ye, Zun-Qiang Xiao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | BMC Surgery |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12893-025-02778-z |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Suppression of popping rates in radiofrequency ablation under perfluorobutane microbubbles for hepatocellular carcinoma
by: Toru Ishikawa, et al.
Published: (2024-12-01) -
Comparison of long-term clinical outcomes between radiofrequency ablation and hepatic resection in patients with small (≤2 cm) hepatocellular carcinoma
by: Young Mi Hong
Published: (2024-12-01) -
Enhanced effect of radiofrequency ablation on HCC by siRNA-PD-L1-endostatin Co-expression plasmid delivered
by: Pengfei Chen, et al.
Published: (2025-03-01) -
Evolution of Liver Resection for Hepatocellular Carcinoma: Change Point Analysis of Textbook Outcome over Twenty Years
by: Yeshong Park, et al.
Published: (2024-12-01) -
Polyoxometalate-based injectable coacervate inhibits HCC metastasis after incomplete radiofrequency ablation via scavenging ROS
by: Meilin Yang, et al.
Published: (2025-01-01)